Drugs / ZR202a-CoV
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05490108 | Jun → Sep 2022 | COVID-19 | Shanghai Zerun Biotechnology Co.,Ltd | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ZR202a-CoV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05490108 ↗ |
| Modality | Vaccine | “SARS-CoV-2 adjuvanted recombinant protein vaccine (variant)” NCT05490108 ↗ |